{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:30:53Z","timestamp":1793316653135,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["[320030_166346]"],"award-info":[{"award-number":["[320030_166346]"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008949","name":"Uniscientia Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00415-020-09767-7","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T14:04:47Z","timestamp":1583417087000},"page":"1802-1811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Depression in myasthenia gravis: a heterogeneous and intriguing entity"],"prefix":"10.1007","volume":"267","author":[{"given":"Yury V.","family":"Gavrilov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana M.","family":"Alekseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Kreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp O.","family":"Valko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-4582","authenticated-orcid":false,"given":"Konrad P.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6147-1960","authenticated-orcid":false,"given":"Yulia","family":"Valko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"issue":"10","key":"9767_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14(10):1023\u20131036","journal-title":"Lancet Neurol"},{"key":"9767_CR2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375:2570\u20132581","journal-title":"N Engl J Med"},{"key":"9767_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1212\/WNL.0000000000002383","volume":"86","author":"Y Valko","year":"2016","unstructured":"Valko Y, Rosengren SM, Jung HH, Straumann D, Landau K, Weber KP (2016) Ocular vestibular evoked myogenic potentials as a test for myasthenia gravis. Neurology 86:660\u2013668","journal-title":"Neurology"},{"key":"9767_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1192\/bjp.136.1.92","volume":"136","author":"J Sneddon","year":"1980","unstructured":"Sneddon J (1980) (1980) Myasthenia gravis\u2014the difficult diagnosis. Br J Psychiatry 136:92\u201393","journal-title":"Br J Psychiatry"},{"key":"9767_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0022-510X(91)90260-E","volume":"106","author":"E Beghi","year":"1991","unstructured":"Beghi E, Antozzi C, Batocchi AP, Cornelio F, Cosi V, Evoli A, Lombardi M, Mantegazza R, Monticelli ML, Piccolo G, Tonali P, Trevisan D, Zarrelli M (1991) Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 106:213\u2013220","journal-title":"J Neurol Sci"},{"key":"9767_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000065639","volume":"21","author":"B Kalb","year":"2002","unstructured":"Kalb B, Matell G, Pirskanen R, Lambe M (2002) Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden. Neuroepidemiology 21:221\u2013225","journal-title":"Neuroepidemiology"},{"key":"9767_CR7","first-page":"157","volume":"19","author":"W Rohr","year":"1992","unstructured":"Rohr W (1992) Myasthenia gravis in the frontier of psychiatric diagnosis. Psychiatr Prax 19:157\u2013163","journal-title":"Psychiatr Prax"},{"key":"9767_CR8","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1017\/sjp.2013.59","volume":"16","author":"E L\u00e1zaro","year":"2013","unstructured":"L\u00e1zaro E, Amayra I, L\u00f3pez-Paz JF, Jomet\u00f3n A, Mart\u00edn N, Caballero P, De Nicol\u00e1s L, Hoffmann H, Kessler H, Ruiz B, Mart\u00ednez O (2013) Facial affect recognition in myasthenia gravis. Span J Psychol 16:E52","journal-title":"Span J Psychol"},{"key":"9767_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0196-0644(83)80475-2","volume":"12","author":"PA Santy","year":"1983","unstructured":"Santy PA (1983) Undiagnosed myasthenia gravis in emergency psychiatric referrals. Ann Emerg Med 12:397\u2013398","journal-title":"Ann Emerg Med"},{"key":"9767_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1176\/jnp.13.1.116-a","volume":"13","author":"K Shinkai","year":"2001","unstructured":"Shinkai K, Ohmori O, Ueda N, Nakamura J, Amano T, Tsuji S (2001) A case of myasthenia gravis preceded by major depression. J Neuropsychiatr Clin Neurosci 13:116\u2013117","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"9767_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4414\/sanp.2007.01850","volume":"158","author":"SJ R\u00fcegg","year":"2007","unstructured":"R\u00fcegg SJ, Dirnhofer S, Buitrago-Tellez CH, Steck AJ, Marsch S (2007) Life-threatening myasthenia gravis masked by a psychiatric disorder. Swiss Arch Neurol Psychiatry 158:150\u2013154","journal-title":"Swiss Arch Neurol Psychiatry"},{"key":"9767_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0140-6736(09)61718-9","volume":"375","author":"N Okamoto","year":"2010","unstructured":"Okamoto N, Furusawa Y, Sakamoto K, Yamamoto T, Kondo Y, Nagafusa Y, Higuchi T (2010) Major depression: what caused the crisis? The Lancet 375:346","journal-title":"The Lancet"},{"key":"9767_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2165\/00023210-200721060-00004","volume":"21","author":"IB Kulaksizoglu","year":"2007","unstructured":"Kulaksizoglu IB (2007) Mood and anxiety disorders in patients with myasthenia gravis; aetiology, diagnosis and treatment. CNS Drugs 21:473\u2013481","journal-title":"CNS Drugs"},{"key":"9767_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1749-6632.1966.tb45488.x","volume":"135","author":"E Meyer","year":"1966","unstructured":"Meyer E (1966) Psychological disturbances in myasthenia gravis: a predictive study. Ann N Y Acad Sci 135:417\u2013423","journal-title":"Ann N Y Acad Sci"},{"key":"9767_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archneur.1993.00540060055018","volume":"50","author":"S Doering","year":"1993","unstructured":"Doering S, Henze T, Schussler G (1993) Coping with myasthenia gravis and implications for psychotherapy. Arch Neurol 50:617\u2013620","journal-title":"Arch Neurol"},{"key":"9767_CR16","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00415-018-8837-4","volume":"265","author":"A Eliasen","year":"2018","unstructured":"Eliasen A, Dalhoff KP, Horwitz H (2018) Neurological diseases and risk of suicide attempt: a case-control study. J Neurol 265:1303\u20131309","journal-title":"J Neurol"},{"key":"9767_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/mus.26069","volume":"58","author":"C Tran","year":"2018","unstructured":"Tran C, Bril V, Katzberg HD, Barnett C (2018) Fatigue is a relevant outcome in patients with myasthenia gravis. Muscle Nerve 58:197\u2013203","journal-title":"Muscle Nerve"},{"key":"9767_CR18","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00415-018-8995-4","volume":"265","author":"TM Alekseeva","year":"2018","unstructured":"Alekseeva TM, Gavrilov YV, Kreis OA, Valko PO, Weber KP, Valko Y (2018) Fatigue in patients with myasthenia gravis. J Neurol 265:2312\u20132321","journal-title":"J Neurol"},{"key":"9767_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1176\/jnp.12.4.499","volume":"12","author":"RH Paul","year":"2000","unstructured":"Paul RH, Cohen RA, Goldstein JM, Gilchrist JM (2000) Severity of mood, self-evaluative, and vegetative symptoms of depression in myasthenia gravis. J Neuropsychiatr Clin Neurosci 12:499\u2013501","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"9767_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1212\/WNL.46.4.1138","volume":"46","author":"A Glennerster","year":"1996","unstructured":"Glennerster A, Palace J, Warburton D, Oxbury S, Newsom-Davis J (1996) Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment. Neurology 46:1138\u20131142","journal-title":"Neurology"},{"key":"9767_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00131402-200303000-00001","volume":"4","author":"J Fisher","year":"2003","unstructured":"Fisher J, Parkinson K, Kothari MJ (2003) Self-reported depressive symptoms in myasthenia gravis. J Clin Neuromuscul Dis 4:105\u2013108","journal-title":"J Clin Neuromuscul Dis"},{"key":"9767_CR22","doi-asserted-by":"publisher","first-page":"e000313","DOI":"10.1136\/bmjopen-2011-000313","volume":"1","author":"Y Suzuki","year":"2011","unstructured":"Suzuki Y, Utsugisawa K, Suzuki S, Nagane Y, Masuda M, Kabasawa C, Shimizu Y, Utsumi H, Uchiyama S, Fujihara K, Suzuki N (2011) Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open 1:e000313","journal-title":"BMJ Open"},{"key":"9767_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4274\/npa.y5611","volume":"50","author":"F Aysal","year":"2013","unstructured":"Aysal F, Karamustafalio\u011flu O, \u00d6z\u00e7elik B, Yilmaz M, Karamustafalio\u011flu N, Yumruk\u00e7al H, Tankaya O (2013) The relationship of symptoms of anxiety and depression with disease severity and treatment modality in myasthenia gravis: a cross-sectional study. Arch Neuropsychiatr 50:295\u2013300","journal-title":"Arch Neuropsychiatr"},{"key":"9767_CR24","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00415-019-09374-1","volume":"266","author":"TM Alekseeva","year":"2019","unstructured":"Alekseeva TM, Kreis OA, Gavrilov YV, Valko PO, Weber KP, Valko Y (2019) Impact of autoimmune comorbidity on fatigue, sleepiness and mood in myasthenia gravis. J Neurol 266:2027\u20132034","journal-title":"J Neurol"},{"key":"9767_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.17650\/2222-8721-2016-6-3-10-16","volume":"6","author":"TM Alekseeva","year":"2016","unstructured":"Alekseeva TM, Kosachev VD, Khalmurzina AN (2016) Clinical and immunological features and treatment of myasthenia gravis in the elderly (review). Neuromuscul Dis 6:10\u201316","journal-title":"Neuromuscul Dis"},{"key":"9767_CR26","first-page":"102","volume":"7","author":"VD Kosachev","year":"2015","unstructured":"Kosachev VD, Lobzin SV, Alekseeva TM, Kreis OA (2015) Clinical and neurological criteria for the diagnosis of myasthenia gravis. Herald of the Northwestern State Medical University named after I.I. Mechnikov 7:102\u2013107","journal-title":"Mechnikov"},{"key":"9767_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/eci.12.34","volume":"8","author":"MN Meriggioli","year":"2012","unstructured":"Meriggioli MN, Sanders DB (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 8:427\u2013438","journal-title":"Expert Rev Clin Immunol"},{"key":"9767_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571","journal-title":"Arch Gen Psychiatry"},{"key":"9767_CR29","first-page":"11","volume":"103","author":"AV Andriushchenko","year":"2003","unstructured":"Andriushchenko AV, Drobizhev MIu, Dobrovol'ski\u012d AV (2003) A comparative validation of the scale CES-D, BDI, and HADS(d) in diagnosis of depressive disorders in general practice. Zhurnal Nevrologii i Psikhiatrii imeni S.S Korsakova 103:11\u201318","journal-title":"Zhurnal Nevrologii i Psikhiatrii imeni S.S Korsakova"},{"key":"9767_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.20792","volume":"21","author":"M Visser","year":"2006","unstructured":"Visser M, Leentjens AF, Marinus J, Stiggelbout AM, van Hilten JJ (2006) Reliability and validity of the Beck depression inventory in patients with Parkinson\u2019s disease. Mov Disord 21:668\u2013672","journal-title":"Mov Disord"},{"key":"9767_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/STROKEAHA.108.527705","volume":"40","author":"A Berg","year":"2009","unstructured":"Berg A, L\u00f6nnqvist J, Palom\u00e4ki H, Kaste M (2009) Assessment of depression after stroke: a comparison of different screening instruments. Stroke 40:523\u2013529","journal-title":"Stroke"},{"key":"9767_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/ene.12932","volume":"23","author":"R Sacco","year":"2016","unstructured":"Sacco R, Santangelo G, Stamenova S, Bisecco A, Bonavita S, Lavorgna L, Trojano L, D\u2019Ambrosio A, Tedeschi G, Gallo A (2016) Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. Eur J Neurol 23:744\u2013750","journal-title":"Eur J Neurol"},{"key":"9767_CR33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123","journal-title":"Arch Neurol"},{"key":"9767_CR34","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/sleep\/31.11.1601","volume":"31","author":"PO Valko","year":"2008","unstructured":"Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR (2008) Validation of the fatigue severity scale in a Swiss cohort. Sleep 31:1601\u20131607","journal-title":"Sleep"},{"key":"9767_CR35","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","volume":"18","author":"JD Fisk","year":"1994","unstructured":"Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF (1994) Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18:S79\u201383","journal-title":"Clin Infect Dis"},{"key":"9767_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ane.12993","volume":"138","author":"YV Gavrilov","year":"2018","unstructured":"Gavrilov YV, Shkilnyuk GG, Valko PO, Stolyarov ID, Ivashkova EV, Ilves AG, Nikiforova IG, Shchelkova OY, Vasserman LI, Vais EE, Valko Y (2018) Validation of the Russian version of the fatigue impact scale and fatigue severity scale in multiple sclerosis patients. Acta Neurol Scand 138:408\u2013416","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"9767_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540\u2013545","journal-title":"Sleep"},{"issue":"1","key":"9767_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/ene.14057","volume":"27","author":"A Bogdan","year":"2019","unstructured":"Bogdan A, Barnett C, Ali A, Al Qwaifly M, Abraham A, Mannan S, Ng E, Bril V (2019) Chronic stress, depression and personality type in patients with myasthenia gravis. Eur J Neurol 27(1):204\u2013209","journal-title":"Eur J Neurol"},{"key":"9767_CR39","doi-asserted-by":"publisher","first-page":"e013278","DOI":"10.1136\/bmjopen-2016-013278","volume":"7","author":"Y Nagane","year":"2017","unstructured":"Nagane Y, Murai H, Imai T, Yamamoto D, Tsuda E, Minami N, Suzuki Y, Kanai T, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Aoki M, Utsugisawa K (2017) Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open 7:e013278","journal-title":"BMJ Open"},{"key":"9767_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"9767_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3389\/fpsyt.2018.00451","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, Tang X (2018) Depressive syndromes in autoimmune disorders of the nervous system: prevalence, etiology, and influence. Front Psychiatry 9:451","journal-title":"Front Psychiatry"},{"key":"9767_CR42","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","volume":"31","author":"YK Kim","year":"2007","unstructured":"Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB (2007) Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1044\u20131053","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9767_CR43","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1038\/tp.2012.120","volume":"2","author":"SJ Sukoff Rizzo","year":"2012","unstructured":"Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, Brandon NJ (2012) Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Trans Psychiatry 2:e199","journal-title":"Trans Psychiatry"},{"key":"9767_CR44","doi-asserted-by":"publisher","first-page":"25886","DOI":"10.1038\/srep25886","volume":"6","author":"A Uzawa","year":"2016","unstructured":"Uzawa A, Kanai T, Kawaguchi N, Oda F, Himuro K, Kuwabara S (2016) Changes in inflammatory cytokine networks in myasthenia gravis. Sci Rep 6:25886","journal-title":"Sci Rep"},{"key":"9767_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","volume":"8","author":"S Twork","year":"2010","unstructured":"Twork S, Wiesmeth S, Klewer J, P\u00f6hlau D, Kugler J (2010) Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 8:129","journal-title":"Health Qual Life Outcomes"},{"key":"9767_CR46","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1170-2","volume":"33","author":"IZ Basta","year":"2012","unstructured":"Basta IZ, Pekmezovi\u0107 TD, Peri\u0107 SZ, Kisi\u0107-Tepav\u010devi\u0107 DB, Rako\u010devi\u0107-Stojanovi\u0107 VM, Stevi\u0107 ZD, Lavrni\u0107 DV (2012) Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci 33:1375\u20131381","journal-title":"Neurol Sci"},{"key":"9767_CR47","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jocn.2015.01.022","volume":"22","author":"S Blum","year":"2015","unstructured":"Blum S, Lee D, Gillis D, McEniery DF, Reddel S, McCombe P (2015) Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci 22:1164\u20131169","journal-title":"J Clin Neurosci"},{"key":"9767_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2018.01.011","volume":"50","author":"NFT Braz","year":"2018","unstructured":"Braz NFT, Rocha NP, Vieira \u00c9LM, Barbosa IG, Gomez RS, Kakehasi AM, Teixeira AL (2018) Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis. J Clin Neurosci 50:41\u201344","journal-title":"J Clin Neurosci"},{"key":"9767_CR49","doi-asserted-by":"publisher","first-page":"e0206754","DOI":"10.1371\/journal.pone.0206754","volume":"13","author":"A Jeong","year":"2018","unstructured":"Jeong A, Min JH, Kang YK, Kim J, Choi M, Seok JM, Kim BJ (2018) Factors associated with quality of life of people with Myasthenia Gravis. PLoS ONE 13:e0206754","journal-title":"PLoS ONE"},{"issue":"1","key":"9767_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/mus.26719","volume":"61","author":"MH Alanazy","year":"2019","unstructured":"Alanazy MH, Binabbad RS, Alromaih NI, Almansour RA, Alanazi SN, Alhamdi MF, Alazwary N, Muayqil T (2019) Severity and depression can impact quality of life in patients with myasthenia gravis. Muscle Nerve 61(1):69\u201373","journal-title":"Muscle Nerve"},{"key":"9767_CR51","first-page":"443e5","volume":"77","author":"G Magni","year":"1988","unstructured":"Magni G, Micaglio GF, Lalli R, Bejato L, Candeago MR, Merskey H, Angelini C (1988) Psychiatric disturbances associated with myasthenia gravis. Acta Psychiatr ScandScandinavica 77:443e5","journal-title":"Acta Psychiatr ScandScandinavica"},{"key":"9767_CR52","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00127-008-0388-z","volume":"43","author":"LS Leach","year":"2008","unstructured":"Leach LS, Christensen H, Mackinnon AJ, Windsor TD, Butterworth P (2008) Gender differences in depression and anxiety across the adult lifespan: the role of psychosocial mediators. Soc Psychiatry Psychiatr Epidemiol 43:983\u2013998","journal-title":"Soc Psychiatry Psychiatr Epidemiol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-020-09767-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:24:02Z","timestamp":1614903842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-020-09767-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9767"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09767-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}